BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2380831)

  • 21. Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity.
    Sahoo SK; Sawa T; Fang J; Tanaka S; Miyamoto Y; Akaike T; Maeda H
    Bioconjug Chem; 2002; 13(5):1031-8. PubMed ID: 12236785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc . protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal rat.
    Maines MD
    Biochim Biophys Acta; 1981 Mar; 673(3):339-50. PubMed ID: 6894392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG.
    Vreman HJ; Lee OK; Stevenson DK
    Am J Med Sci; 1991 Dec; 302(6):335-41. PubMed ID: 1772116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sn-protoporphyrin: a consideration of the first clinical trial in human neonates.
    Stevenson DK; Vreman HJ
    Pediatrics; 1988 Jun; 81(6):881-2. PubMed ID: 3285317
    [No Abstract]   [Full Text] [Related]  

  • 25. Lack of inhibition of intestinal heme oxygenase by antibiotics and tin-protoporphyrin.
    Hintz SR; Kim CB; Vreman HJ; Stevenson DK
    Pediatr Res; 1988 Jan; 23(1):50-3. PubMed ID: 3340445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of heme oxygenase inhibitors to the spleen markedly increases their ability to diminish bilirubin production.
    Landaw SA; Drummond GS; Kappas A
    Pediatrics; 1989 Dec; 84(6):1091-6. PubMed ID: 2587139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.
    Berglund L; Angelin B; Hultcrantz R; Einarsson K; Emtestam L; Drummond G; Kappas A
    Gut; 1990 Aug; 31(8):899-904. PubMed ID: 2387514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of action and tissue distribution of zinc protoporphyrin in neonatal rats.
    Rodgers PA; Seidman DS; Wei PL; Dennery PA; Stevenson DK
    Pediatr Res; 1996 Jun; 39(6):1041-9. PubMed ID: 8725267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects.
    Berglund L; Angelin B; Blomstrand R; Drummond G; Kappas A
    Hepatology; 1988; 8(3):625-31. PubMed ID: 3371880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of ritodrine hydrochloride on bilirubin production in neonatal rats.
    Ochikubo CG; Sunshine SE; Vreman HJ; Ferguson JE; Stevenson DK
    Pediatr Pharmacol (New York); 1986; 5(4):247-52. PubMed ID: 3755522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon monoxide production by nonbacterial sources after heme feeding of neonatal rats.
    Stevenson DK; Hamori CJ; Carlton RR; Castillo RO; Kerner JA; Vreman HJ
    Biol Neonate; 1990; 57(3-4):238-42. PubMed ID: 2322605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of carbon monoxide production by tin-protoporphyrin.
    Sassa S
    J Pediatr Gastroenterol Nutr; 1987; 6(2):167-71. PubMed ID: 3694342
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of heme oxygenase activity using a microparticle formulation of zinc protoporphyrin in an acute hemolytic newborn mouse model.
    Fujioka K; Kalish F; Wong RJ; Stevenson DK
    Pediatr Res; 2016 Feb; 79(2):251-7. PubMed ID: 26488552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological and biological effects of tin-protoporphyrin on neonatal hyperbilirubinemic Gunn rats.
    Nagae H; Keino H; Watanabe K; Kashiwamata S
    Pediatr Res; 1988 Aug; 24(2):209-12. PubMed ID: 3186333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical properties of the heme oxygenase inhibitor, Sn-protoporphyrin. Interactions with apomyoglobin and human serum albumin.
    Breslow E; Chandra R; Kappas A
    J Biol Chem; 1986 Mar; 261(7):3135-41. PubMed ID: 3753975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolism.
    Drummond GS; Galbraith RA; Sardana MK; Kappas A
    Arch Biochem Biophys; 1987 May; 255(1):64-74. PubMed ID: 3592668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of light on metalloporphyrin-treated newborn mice.
    Wong RJ; Schulz S; Espadas C; Vreman HJ; Rajadas J; Stevenson DK
    Acta Paediatr; 2014 May; 103(5):474-9. PubMed ID: 24417721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tin-protoporphyrin inhibits carbon monoxide production in adult male Wistar rats with common bile duct ligation.
    McMillan JJ; Vreman HJ; Stevenson DK
    J Pediatr Gastroenterol Nutr; 1987; 6(5):795-8. PubMed ID: 3694375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of oral administration of tin and zinc protoporphyrin on neonatal and adult rat tissue heme oxygenase activity.
    Vreman HJ; Hintz SR; Kim CB; Castillo RO; Stevenson DK
    J Pediatr Gastroenterol Nutr; 1988; 7(6):902-6. PubMed ID: 3199276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha).
    Sassa S; Drummond GS; Bernstein SE; Kappas A
    J Exp Med; 1985 Sep; 162(3):864-76. PubMed ID: 3839840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.